Delivery Order SPE2DB22D2206-SPE2DB25FGH04
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMGALITY 300 MG (100 MG X3SYR)ML, a prescription medication. The contract has a firm fixed price, with a ceiling value of $1,547.00, and an ultimate completion date of May 16, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,493.40, is for the delivery of EMGALITY 300 MG (100 MG X3SYR)ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.40, is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a $1,037.40 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML SYRINGEML. The contract has an ultimate completion date of June 9, 2025 and is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a medication, with a ceiling value of $1,319.16 and a performance period ending on June 18, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has a firm fixed price of $2,759.96 and a completion date of June 11, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a ceiling value of $1,669.08 and a performance period that runs through December 21, 2023. This award is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.30 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,320.50, is a Firm Fixed Price Delivery Order for the supply of the medication EMGALITY 300 MG (100 MG X3SYR)ML. The contract has an ultimate completion date of March 17, 2025. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $1,081.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of EMGALITY 300 MG (100 MG X 3 SYR)ML, a pharmaceutical product, with a period of performance through May 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...